Average Co-Inventor Count = 4.08
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (13 from 3,681 patents)
2. E. R. Squibb Sons, Inc. (13 from 1,624 patents)
3. Astrazeneca Ab (1 from 1,500 patents)
4. Bristol-myers Squibb (1 from 36 patents)
28 patents:
1. 9453039 - Crystal structures of SGLT2 inhibitors and processes for preparing same
2. 8501698 - Crystal structures of SGLT2 inhibitors and processes for preparing same
3. 7932379 - Methods of producing C-aryl glucoside SGLT2 inhibitors
4. 7919598 - Crystal structures of SGLT2 inhibitors and processes for preparing same
5. 7375213 - Methods of producing C-aryl glucoside SGLT2 inhibitors
6. 6087383 - Bisulfate salt of HIV protease inhibitor
7. 5874578 - Process for preparing guanine-containing antiviral agents and purinyl
8. 5618946 - 7-oxabicycloheptane carboxylic acid prostaglandin analog intermediates
9. 5608064 - Purinyl salts useful for preparing guanine containing antiviral agents
10. 5539130 - 7-Oxabicycloheotane carboxylic acid prostaglandin analog intermediates
11. 5539126 - Method for preparing homochiral maleimide intermediates, via silylation
12. 5525726 - Process for the preparation of an antiviral agent
13. 5516903 - Process for preparing
14. 5512690 - 7-oxabicycloheptane carboxylic acid prostaglandin analog intermediates
15. 5508445 - 7-oxabicycloheptane carboxylic acid protaglandin analog intermediates